Protein clustering and interactome analysis in Parkinson and Alzheimer’s diseases

Archives of Iranian Medicine

Volumn 19, Issue 2, 2016, Pages 101-109

  Rezaei Tavirani, Mostafa ^a   Zamanian Azodi, Mona ^a   Rajabi, Sepideh ^a   Masoudi Nejad, Ali ^b   Rostami Nejad, Mohammad ^c   Rahmatirad, Sara ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer s disease; Clustering; Cytoscape v: 3.2.1; DAVID bioinformatics resources; Parkinson s disease; R Programming Language Software

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 7C; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 6A1; CYCLOOXYGENASE 6B1; CYCLOOXYGENASE 7A1; CYCLOOXYGENASE 8A; CYTOCHROME B; CYTOCHROME C; CYTOCHROME C1; PROSTAGLANDIN SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SUCCINATE DEHYDROGENASE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; PROTEIN;

ALZHEIMER DISEASE; ARTICLE; GENE ONTOLOGY; HUMAN; PARKINSON DISEASE; PROTEIN ANALYSIS; BIOLOGY; GENETICS; METABOLISM; PROTEIN PROTEIN INTERACTION;

ALZHEIMER DISEASE; COMPUTATIONAL BIOLOGY; GENE ONTOLOGY; HUMANS; PARKINSON DISEASE; PROTEIN INTERACTION MAPS; PROTEINS;

EID: 84957575242     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003; 422(6938): 198-207.
2. King AD, Przulj N, Jurisica I. Protein complex prediction via cost-based clustering. Bioinformatics. 2004; 20(17): 3013-3020.
3. Zali H, Rezaei Tavirani M. Meningioma protein-protein interaction network. Arch Iran Med. 2014; 17(4): 262.
4. Safari-Alighiarloo N, Taghizadeh M, Rezaei-Tavirani M, Goliaei B, Peyvandi A. Protein-protein interaction networks (PPI) and complex diseases. Gastroenterol Hepatol bed bench. 2014; 7(1): 17.
5. Renaud J, Nabavi SM, Daglia M, Nabavi SM, Martinoli MG. Epigal-locatechin-3-gallate, a promising molecule for Parkinson’s disease? Rejuvenation Res. 2015; 18(3): 257-269.
6. Zali H, Zamanian-Azodi M, Rezaei Tavirani M, Akbar-zadeh Baghban A. Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer’s Disease. Iran JPharm Res. 2015; 14(1): 291.
7. Ghamari E, Zali H, Rezaei Tavirani M, Hesami Takalu S, Goshadrou F, Ahmadi N, Zamaheni S, et al. Proteomic study in the rat hippocampus as a measure of human Alzheimer’s disease. Koomesh. 2015; 16(4): 611-620.
8. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM. Gene ontology: tool for the unification of biology. Nature Genetics. 2000; 25(1): 25-29.
9. Consortium GO. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004; 32(suppl 1): 258-261.
10. Consortium GO. Creating the gene ontology resource: design and implementation. Genome Res. 2001; 11(8): 1425-1433.
11. Nia YZ, Majd HA, Azodi M, Khayyer N. Using partitioning and non-partitioning clustering algorithms for included proteins sequences in esophagus, stomach and colon cancer. J Paramed Sci. 2011; 2(2): 9-16.
12. Brun C, Herrmann C, Guenoche A. Clustering proteins from interaction networks for the prediction of cellular functions. BMC Bioinfor-matics. 2004; 5(1): 95.
13. Gil J, Esteban M. Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis. 2000; 5(2): 107-114.
14. Zamanian Azodi M, Rezaei Tavirani M, Rahmatirad S, Hadi Hasanzadeh,Majid Rezaei Tavirani, Samaneh Sadat Seyyedi. Protein-Protein Interaction Network could reveal the relationship between the breast and colon cancer. Gastroenterol Hepatol Bed Bench. 2015; 8(3): 215-224.
15. Phizicky EM, Fields S. Protein-protein interactions: methods for detection and analysis. MicrobiolMol Biol Rev. 1995; 59(1): 94-123.
16. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck F, Goehler H, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005; 122(6): 957-968.
17. Soheili M, Rezaei Tavirani M, Salami M. Clearance of amyloid beta plaques from brain of Alzheimeric rats by lavandula angustifolia. Neu-rosci Med. 2012; 3(4): 362-367.
18. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Bar-berger-Gateau P, et al. Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol. 2010; 9(11): 1118-1127.
19. Habibi E, Masoudi-Nejad A, Abdolmaleky HM, Haggarty S. Emerging roles of epigenetic mechanisms in Parkinson’s disease. Funct In-tegr Genomics. 2011; 11(4): 523-537.
20. Deep-Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med, 2001; 345(13): 956-963.
21. Hoang QQ. Pathway for Parkinson disease. Proc Natl Acad Sci. 2014; 111(7): 2402-2403.
22. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids Res. 2000; 28(1): 27-30.
23. Camon E, Magrane M, Barrell D, Barrell D, Lee V, Dimmer E, Maslen J. The gene ontology annotation (GOA) database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res. 2004; 32: 262-266.
24. Qiu X, Brooks AI, Klebanov L, Yakovlev A. The effects of normalization on the correlation structure of microarray data. BMC Bioinformat-ics. 2005; 6: 120.
25. Wolting C, McGlade CJ, Tritchler D. Cluster analysis of protein array results via similarity of gene ontology annotation. BMC Bioinformat-ics. 2006; 7(1): 1-13
26. Zarnegarnia Y, Majd HA, Rezaei-Tavirani R, Khaier N, Maboodi AAK. Application of fuzzy clustering in analysis of included proteins in esophagus, stomach and colon cancers based on similarity of gene ontology annotation. Koomesh. 2010; 12(1): 14-21.
27. Nordstrom KJ, Almen MS, Edstam MM, Fredriksson R, Schioth H. Independent HHsearch, Needleman--Wunsch-based, and motif analyses reveal the overall hierarchy for most of the G protein-coupled receptor families. Mol Biol Evol. 2011; 28(9): 2471-2480.
28. Owen DM, Williamson D, Magenau A. Optical techniques for imaging membrane domains in live cells (live-cell palm of protein clustering). Methods Enzymol. 2012; 504: 221-235.
29. Rousseeuw PJ. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math. 1987; 20: 53-65
30. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2008; 4(1): 44-57.
31. Da Wei Huang BTS, Stephens R, Baseler MW,Baseler M, Lane C, Lempicki R. DAVID gene ID conversion tool. Bioinformation. 2008; 2(10): 428-430.
32. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37(1): 1-13.
33. Rojo DR, Prough DS, Falduto MT, Boone DR, Micci MA, Kahrig KM, et al. Influence of stochastic gene expression on the cell survival rheostat after traumatic brain injury. PLoS One. 2011; 6(8): e23111.
34. Chattopadhyay AK, Nasiev D, Flower DR. A statistical physics perspective on alignment-independent protein sequence comparison. Bioinformatics. 2015; 31(15): 2469-2474.
35. Chen X, Yan SD. Mitochondrial abeta: a potential cause of metabolic dysfunction in alzheimer’s disease. IUBMB Life. 2006; 58: 686-694